Cargando…
Intravenous Glucocorticoid Treatment for Korean Graves' Ophthalmopathy Patients
BACKGROUND: High-dose intravenous steroids are the first-line treatment for patients with moderate-to-severe and active Graves' ophthalmopathy (GO). We aimed to investigate the response rate of methylprednisolone (MPD) treatment among Korean patients with active moderate-to-severe GO and to ide...
Autores principales: | Ahn, Hwa Young, Lee, Jeong Kyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295605/ https://www.ncbi.nlm.nih.gov/pubmed/32537950 http://dx.doi.org/10.3346/jkms.2020.35.e177 |
Ejemplares similares
-
Efficacy and Safety of Different Intravenous Glucocorticoid Regimens in the Treatment of Graves' Ophthalmopathy: A Meta-Analysis
por: Chen, Jing, et al.
Publicado: (2021) -
Assessment of Quality of Life and Depression in Korean Patients with Graves' Ophthalmopathy
por: Lee, Hun, et al.
Publicado: (2010) -
Corticosteroids in Moderate-To-Severe Graves’ Ophthalmopathy: Oral or Intravenous Therapy?
por: Penta, Laura, et al.
Publicado: (2019) -
Sex-specific risk factors associated with graves’ orbitopathy in Korean patients with newly diagnosed graves’ disease
por: Lee, Jooyoung, et al.
Publicado: (2023) -
Autophagy in graves’ ophthalmopathy
por: Chen, Yu-Qing, et al.
Publicado: (2023)